This study is testing a special bed sheet sensor, called the Tactilus Bodyfitter sensor, to see if it can accurately detect your body position, especially after a generalized tonic-clonic (GTC) seizure. GTC seizures are a type of seizure that affects the whole brain. The goal is to see if this sensor can help prevent Sudden Unexpected Death in Epilepsy (SUDEP) by automatically repositioning people who are lying face down after a seizure. You may be able to join if you are an adult (18 or older) with drug-resistant epilepsy, meaning your seizures haven't been controlled by at least two anti-seizure medications, and you have a history of electroclinical seizures. The study aims to accurately detect body position within 5 seconds and successfully reposition people from lying face down to a recovery position within 30 seconds. The current status of this study is unclear.

Study design

This is an interventional study planning to enroll 50 participants. It is an exploratory study using a commercial bed sheet sensor and software.

What's involved

You would be monitored while lying on the Tactilus Bodyfitter sensor during your admission to the BWH EMU (Epilepsy Monitoring Unit).

Compensation

Not stated in the trial record.

Follow-up

Body position detection is measured at 5 seconds, and repositioning is measured at 30 seconds.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.